Glucose and Insulin Differently Regulate Gluconeogenic and Ureagenic Gene Expression

Area of Science:

• Metabolic regulation
• Gene expression analysis
• Hepatic pathways

Background:

• Glucose and insulin activate glycolysis and lipogenesis via ChREBP and SREBP1c.
• The distinct roles of glucose and insulin in regulating gluconeogenic and ureagenic genes are not fully understood.

Purpose of the Study:

• To investigate the differential roles of insulin signaling and ChREBP in regulating hepatic gene expression.
• To compare the effects of an insulin antagonist (S961) and Chrebp deletion on metabolic pathways.

Main Methods:

• Utilized an insulin antagonist (S961) and Chrebp-deleted mice models.
• Analyzed hepatic gene expression for glycolysis, lipogenesis, gluconeogenesis, and ureagenesis.
• Measured plasma metabolites and hepatic triglyceride content.

Main Results:

• S961 increased plasma glucose and insulin; Chrebp deletion had no additive effect.
• Both S961 and Chrebp deletion decreased glycolytic and lipogenic gene expression.
• S961 upregulated gluconeogenic genes, while Chrebp deletion downregulated most, except Pck1.
• S961 increased ureagenic gene expression and altered related metabolite concentrations; Chrebp deletion had no effect.

Conclusions:

• Insulin, rather than glucose, primarily regulates ureagenic gene expression.
• Insulin and glucose exert opposing regulatory effects on gluconeogenic gene expression.